{"id":2288,"date":"2026-10-01T17:21:04","date_gmt":"2026-10-01T15:21:04","guid":{"rendered":"https:\/\/infoimasd.com\/?p=2288"},"modified":"2026-10-01T17:21:05","modified_gmt":"2026-10-01T15:21:05","slug":"entrevista-ion-arocena-asebio-biospain","status":"publish","type":"post","link":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/","title":{"rendered":"Entrevista a Ion Arocena, director general de AseBio: \u00abel reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\u00bb"},"content":{"rendered":"\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>Entrevistamos a Ion Arocena, director general de AseBio<\/strong>, la asociaci\u00f3n organizadora de <a href=\"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/biospain-2026-financiacion-transferencia-tecnologica\/\" data-type=\"post\" data-id=\"2274\">BioSpain, el mayor evento biotecnol\u00f3gico de Espa\u00f1a.<\/a> Analizamos el \u00e9xito de la edici\u00f3n 2026 celebrada en Bilbao, de la marcha y de los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y del futuro que le espera a la actividad con la futura Biotech Act II.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">A juicio de Arocena, <strong>el gran reto de las biotech es atraer inversi\u00f3n privada<\/strong>, y a\u00f1ade que eso pasa por crear un entorno regulatorio favorables que cuente con incentivos, sobre todo fiscales, que a su parecer no se est\u00e1n explotando al m\u00e1ximo.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Entrevista a Ion Arocena (AseBio) en BioSpain: &quot;el gran reto es la atracci\u00f3n de inversi\u00f3n privada&quot;\" width=\"500\" height=\"281\" data-src=\"https:\/\/www.youtube.com\/embed\/x5UMTSanFII?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"0\"><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Analizamos con el director general de AseBio el \u00e9xito de BioSpain 2026, de la marcha y de los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y del futuro que le espera a la actividad con la futura Biotech Act II.<\/p>\n","protected":false},"author":1,"featured_media":2289,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[16],"tags":[376,1086,377,1091,379,1094,1095],"class_list":["post-2288","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-entrevistas","tag-asebio","tag-biospain","tag-biospain-2026","tag-biotech-act-ii","tag-biotecnologia","tag-financiacion-biotecnologica","tag-ion-arocena"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Entrevista a Ion Arocena, director general de AseBio: &quot;el reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable&quot; - INFO I+D<\/title>\n<meta name=\"description\" content=\"Entrevista a Ion Arocena sobre los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y el futuro que le espera con la Biotech Act II.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Entrevista a Ion Arocena, director general de AseBio: &quot;el reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable&quot; - INFO I+D\" \/>\n<meta property=\"og:description\" content=\"Entrevista a Ion Arocena sobre los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y el futuro que le espera con la Biotech Act II.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/\" \/>\n<meta property=\"og:site_name\" content=\"INFO I+D\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-01T15:21:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-01T15:21:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/10\/Portada-Entrevista-Ion-Arocena-1024x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Miguel Guti\u00e9rrez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Miguel Guti\u00e9rrez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/\"},\"author\":{\"name\":\"Miguel Guti\u00e9rrez\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/person\\\/7d19b1faaeac5b8ab56fbdb8f46fc85e\"},\"headline\":\"Entrevista a Ion Arocena, director general de AseBio: \u00abel reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\u00bb\",\"datePublished\":\"2026-10-01T15:21:04+00:00\",\"dateModified\":\"2026-10-01T15:21:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/\"},\"wordCount\":140,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Portada-Entrevista-Ion-Arocena.png\",\"keywords\":[\"AseBio\",\"BIOSPAIN\",\"BIOSPAIN 2026\",\"Biotech Act II\",\"Biotecnolog\u00eda\",\"financiaci\u00f3n biotecnol\u00f3gica\",\"Ion Arocena\"],\"articleSection\":[\"Entrevistas\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/\",\"name\":\"Entrevista a Ion Arocena, director general de AseBio: \\\"el reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\\\" - INFO I+D\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Portada-Entrevista-Ion-Arocena.png\",\"datePublished\":\"2026-10-01T15:21:04+00:00\",\"dateModified\":\"2026-10-01T15:21:05+00:00\",\"description\":\"Entrevista a Ion Arocena sobre los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y el futuro que le espera con la Biotech Act II.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Portada-Entrevista-Ion-Arocena.png\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Portada-Entrevista-Ion-Arocena.png\",\"width\":1672,\"height\":941},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/10\\\/01\\\/entrevista-ion-arocena-asebio-biospain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/infoimasd.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entrevista a Ion Arocena, director general de AseBio: \u00abel reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\u00bb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#website\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/\",\"name\":\"infoimasd.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/infoimasd.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\",\"name\":\"INFO I+D\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-INFO-ID-RELIEVE-150-X-150.png\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-INFO-ID-RELIEVE-150-X-150.png\",\"width\":1254,\"height\":1254,\"caption\":\"INFO I+D\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/person\\\/7d19b1faaeac5b8ab56fbdb8f46fc85e\",\"name\":\"Miguel Guti\u00e9rrez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1792433451\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1792433451\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1792433451\",\"caption\":\"Miguel Guti\u00e9rrez\"},\"description\":\"Director de INFO I+D\",\"sameAs\":[\"https:\\\/\\\/infoimasd.com\\\/\"],\"url\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/author\\\/admin8536\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entrevista a Ion Arocena, director general de AseBio: \"el reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\" - INFO I+D","description":"Entrevista a Ion Arocena sobre los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y el futuro que le espera con la Biotech Act II.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/","og_locale":"es_ES","og_type":"article","og_title":"Entrevista a Ion Arocena, director general de AseBio: \"el reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\" - INFO I+D","og_description":"Entrevista a Ion Arocena sobre los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y el futuro que le espera con la Biotech Act II.","og_url":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/","og_site_name":"INFO I+D","article_published_time":"2026-10-01T15:21:04+00:00","article_modified_time":"2026-10-01T15:21:05+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/10\/Portada-Entrevista-Ion-Arocena-1024x576.png","type":"image\/png"}],"author":"Miguel Guti\u00e9rrez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Miguel Guti\u00e9rrez","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#article","isPartOf":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/"},"author":{"name":"Miguel Guti\u00e9rrez","@id":"https:\/\/infoimasd.com\/#\/schema\/person\/7d19b1faaeac5b8ab56fbdb8f46fc85e"},"headline":"Entrevista a Ion Arocena, director general de AseBio: \u00abel reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\u00bb","datePublished":"2026-10-01T15:21:04+00:00","dateModified":"2026-10-01T15:21:05+00:00","mainEntityOfPage":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/"},"wordCount":140,"commentCount":0,"publisher":{"@id":"https:\/\/infoimasd.com\/#organization"},"image":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#primaryimage"},"thumbnailUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/10\/Portada-Entrevista-Ion-Arocena.png","keywords":["AseBio","BIOSPAIN","BIOSPAIN 2026","Biotech Act II","Biotecnolog\u00eda","financiaci\u00f3n biotecnol\u00f3gica","Ion Arocena"],"articleSection":["Entrevistas"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/","url":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/","name":"Entrevista a Ion Arocena, director general de AseBio: \"el reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\" - INFO I+D","isPartOf":{"@id":"https:\/\/infoimasd.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#primaryimage"},"image":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#primaryimage"},"thumbnailUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/10\/Portada-Entrevista-Ion-Arocena.png","datePublished":"2026-10-01T15:21:04+00:00","dateModified":"2026-10-01T15:21:05+00:00","description":"Entrevista a Ion Arocena sobre los retos que enfrenta el sector biotecnol\u00f3gico espa\u00f1ol, y el futuro que le espera con la Biotech Act II.","breadcrumb":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#primaryimage","url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/10\/Portada-Entrevista-Ion-Arocena.png","contentUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/10\/Portada-Entrevista-Ion-Arocena.png","width":1672,"height":941},{"@type":"BreadcrumbList","@id":"https:\/\/infoimasd.com\/index.php\/2026\/10\/01\/entrevista-ion-arocena-asebio-biospain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infoimasd.com\/"},{"@type":"ListItem","position":2,"name":"Entrevista a Ion Arocena, director general de AseBio: \u00abel reto es continuar atrayendo inversi\u00f3n privada con un marco de inventivos m\u00e1s favorable\u00bb"}]},{"@type":"WebSite","@id":"https:\/\/infoimasd.com\/#website","url":"https:\/\/infoimasd.com\/","name":"infoimasd.com","description":"","publisher":{"@id":"https:\/\/infoimasd.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infoimasd.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/infoimasd.com\/#organization","name":"INFO I+D","url":"https:\/\/infoimasd.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/#\/schema\/logo\/image\/","url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/05\/Logo-INFO-ID-RELIEVE-150-X-150.png","contentUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/05\/Logo-INFO-ID-RELIEVE-150-X-150.png","width":1254,"height":1254,"caption":"INFO I+D"},"image":{"@id":"https:\/\/infoimasd.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infoimasd.com\/#\/schema\/person\/7d19b1faaeac5b8ab56fbdb8f46fc85e","name":"Miguel Guti\u00e9rrez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1792433451","url":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1792433451","contentUrl":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1792433451","caption":"Miguel Guti\u00e9rrez"},"description":"Director de INFO I+D","sameAs":["https:\/\/infoimasd.com\/"],"url":"https:\/\/infoimasd.com\/index.php\/author\/admin8536\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/10\/Portada-Entrevista-Ion-Arocena.png","_links":{"self":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/2288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/comments?post=2288"}],"version-history":[{"count":2,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/2288\/revisions"}],"predecessor-version":[{"id":2291,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/2288\/revisions\/2291"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/media\/2289"}],"wp:attachment":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/media?parent=2288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/categories?post=2288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/tags?post=2288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}